Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational, Retrospective and Multicenter Study to Evaluate the Clinical Benefit of Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib

NCT02056080 is registered in ClinicalTrials.gov with MedSIR as lead sponsor.

NCT NCT02056080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02056080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational, Retrospective and Multicenter Study to Evaluate the Clinical Benefit of Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib
Lead sponsor
MedSIR
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
January 31, 2014
Enrollment
111 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm